Glycoscience has developed a new technological platform that represents the launch of a totally new concept in the processes of releasing compounds for topical application on human skin.
Innovation based on the enzymatic modification of alcohols with biological activity, will allow producers of insect repellants, drugs, medical devices and cosmetics revolutionise their marketing experiences.
This technology, which redefines product release times, will provide manufacturers in many large economic sectors with the ability to rethink application times, duration, dose, potency and efficacy, concentrations of active ingredients, use of toxicity warnings as well as the reliability of its products and, in the last case, the improvement of its operating margins.